These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28730788)

  • 41. DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation.
    Mialon A; Sankinen M; Söderström H; Junttila TT; Holmström T; Koivusalo R; Papageorgiou AC; Johnson RS; Hietanen S; Elenius K; Westermarck J
    Mol Cell Biol; 2005 Jun; 25(12):5040-51. PubMed ID: 15923621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell cycle stage-specific differential expression of topoisomerase I in tobacco BY-2 cells and its ectopic overexpression and knockdown unravels its crucial role in plant morphogenesis and development.
    Singh BN; Mudgil Y; John R; Achary VM; Tripathy MK; Sopory SK; Reddy MK; Kaul T
    Plant Sci; 2015 Nov; 240():182-92. PubMed ID: 26475198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
    Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
    Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons.
    Uday Bhanu M; Kondapi AK
    Neurotoxicology; 2010 Dec; 31(6):730-7. PubMed ID: 20600288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.
    Durbecq V; Desmed C; Paesmans M; Cardoso F; Di Leo A; Mano M; Rouas G; Leroy JY; Sotiriou C; Piccart M; Larsimont D
    Int J Oncol; 2004 Nov; 25(5):1473-9. PubMed ID: 15492841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The expression of ki-67, topoIIalpha in laryngeal squamous cell carcinoma].
    Deng G; Yang C; Chen W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 May; 19(9):396-8. PubMed ID: 16075972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies.
    Bronstein IB; Vorobyev S; Timofeev A; Jolles CJ; Alder SL; Holden JA
    Oncol Res; 1996; 8(1):17-25. PubMed ID: 8704283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.
    Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M
    Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
    Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Blum RH; Zeleniuch-Jacquotte A
    Clin Cancer Res; 1997 Aug; 3(8):1245-52. PubMed ID: 9815806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
    Morris EJ; Geller HM
    J Cell Biol; 1996 Aug; 134(3):757-70. PubMed ID: 8707853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
    Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
    J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human DNA topoisomerase II-alpha.
    Martinchick J; Rahn M; Jolles C; Holden J
    Int J Oncol; 1997 Jun; 10(6):1229-34. PubMed ID: 21533509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Origin and evolution of DNA topoisomerases.
    Forterre P; Gribaldo S; Gadelle D; Serre MC
    Biochimie; 2007 Apr; 89(4):427-46. PubMed ID: 17293019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
    Buckwalter CA; Lin AH; Tanizawa A; Pommier YG; Cheng YC; Kaufmann SH
    Cancer Res; 1996 Apr; 56(7):1674-81. PubMed ID: 8603419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
    Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
    Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.